Genomic characterization of clinical Burkholderia semiarida SYBS718, a Burkholderia cepacia complex strain isolated from an immunocompromised patient
FEMS Microbiology Letters · 2026
DOI: 10.1093/femsle/fnag117 ↗Kurz gefasst
Fachartikel in der Zeitschrift FEMS Microbiology Letters, 2026. Verfasst von Huaxiong Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical & Central Laboratory of Sanya People's Hospital, Sanya 572000, Hainan, China. Hauptthemen laut MEDLINE: Burkholderia Infections, Burkholderia cepacia complex, Immunocompromised Host, Genome, Bacterial. Die Arbeit nennt 58 Literaturangaben. Gefördert von: Academicians of Hainan Province.
Abstract (Originalsprache)
Burkholderia semiarida, a plant-pathogenic species within the Burkholderia cepacia complex (Bcc), has emerged as a worrying opportunistic pathogen causing serious respiratory infections in patients with cystic fibrosis (CF). In this study, strain SYBS718 was isolated from the blood and sputum of an immunocompromised patient. Conventional MALDI-TOF mass spectrometry and 16S rRNA sequencing misidentified this isolate as Burkholderia cenocepacia, whereas whole-genome sequencing enabled accurate species confirmation. Genomic analysis predicted a total of 569 virulence factors, 11 antibiotic resistance genes, and 1112 type III secretion system effector proteins related genes through the core databases of VFDB, CARD, and TS33. The virulence factors mainly include type VI secretion system (T6SS), type III secretion system (T3SS), iron uptake system, flagella, and type IV pili (TFP), which are associated with bacterial colonization, invasion, and pathogenicity. And the antibiotic resistance genes are primarily associated with fluoroquinolone, tetracycline, and aminoglycoside antibiotics. This study is the first to perform comprehensive genomic characterization of a clinical B. semiarida isolate. Our findings reveal the limitations of routine Bcc identification, and provide fundamental genomic data for further clinical and mechanistic research on this emerging opportunistic pathogen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical & Central Laboratory of Sanya People's Hospital, Sanya 572000, Hainan, China.
- Department of Laboratory Medicine, The First Affiliated Hospital of Hainan Medical University, Haikou 570102, Hainan, China.
Förderung
- Academicians of Hainan Province
Zitieren
APA
Zhu, H., Li, H., Xu, L., Fu, X., Wang, C., Zhong, S., & Wang, L. (2026). Genomic characterization of clinical Burkholderia semiarida SYBS718, a Burkholderia cepacia complex strain isolated from an immunocompromised patient. FEMS Microbiology Letters. https://doi.org/10.1093/femsle/fnag117
Vancouver
Zhu H, Li H, Xu L, Fu X, Wang C, Zhong S, et al. Genomic characterization of clinical Burkholderia semiarida SYBS718, a Burkholderia cepacia complex strain isolated from an immunocompromised patient. FEMS Microbiology Letters. 2026. doi:10.1093/femsle/fnag117
BibTeX
@article{Zhu2026,
author = {Zhu, Huaxiong and Li, Hao and Xu, Lixia and Fu, Xiaoying and Wang, Chongzhen and Zhong, Shan and Wang, Licheng},
title = {Genomic characterization of clinical Burkholderia semiarida SYBS718, a Burkholderia cepacia complex strain isolated from an immunocompromised patient},
journal = {FEMS Microbiology Letters},
year = {2026},
doi = {10.1093/femsle/fnag117}
}
EUVIMED